ASCENDAS GENOMICS
Guangdong Tengfei Gene Technology Co., Ltd. (hereinafter referred to as Tengfei Gene) was established in 2014. It is headquartered in the National Health Industry Base of Torch Development Zone, Zhongshan City, Guangdong Province. It has an office and R&D production area of 3,100 square meters. It has research and research in Guangzhou and San Francisco. B. Ascendas was founded by the senior research and development director of Life Technologies of the United States ( Thermo Fisher Scient... ific) and invested by Sun Yat-sen University Daan Gene Co., Ltd. The company specializes in the development of genetic testing programs, medical testing reagents and bioinformatics data analysis management software. At the same time, the company has entered into strategic partnerships with Sun Yat-sen University of Daan Gene Co., Ltd. and Life Technologies of the United States (Thermo Fisher Scientific) to jointly promote the wide application of genetic testing technology.
ASCENDAS GENOMICS
Industry:
Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Zhongshan, Anhui, China
Country:
China
Website Url:
http://www.ascendgene.com
Status:
Active
Contact:
0760-89965088
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SSL By Default HSTS Pound Sterling Japanese Yen DigiCert SSL Encryption Everywhere China Telecom
Similar Organizations
PharmaSens
PharmaSens is a company focussing on the development of next-generation devices for diabetes care.
Simplyfeye Softwares
Simplyfeye Softwares is focused on the development of products for the pharmaceutical and biotechnology companies.
Swiss Rockets
Swiss Rockets focuses on the development of new treatment therapies and clinical drugs for cancer patients.
Current Employees Featured
Official Site Inspections
http://www.ascendgene.com
- Host name: 252.113.65.125.broad.ls.sc.dynamic.163data.com.cn
- IP address: 125.65.113.252
- Location: China
- Latitude: 30.6667
- Longitude: 104.0667
- Timezone: Asia/Shanghai
More informations about "Ascendas Genomics"
广东腾飞基因科技股份有限公司
广东腾飞基因科技股份有限公司成立于2014年9月，总部位于粤港澳大湾区中心地带的广东省中山市，在广州、南京和美国旧金山设有科研和业务中心，并设有gmp标准生产厂房。See details»
AscentGene | High-quality cell line and protein services
AscentGene is a leading biotechnology company that provides expertise and services for establishing cell lines used in protein expression, studying gene function, and monoclonal …See details»
AscentGene - Crunchbase Company Profile & Funding
AscentGene specializes in cell lines services, protein & enzymes research, gene function studies & monoclonal antibody production solutions.See details»
Ascend Gene and Cell Therapies Ltd. (Ascend GCTx)
Jun 22, 2021 Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for …See details»
AscentGene - Contacts, Employees, Board Members, Advisors
AscentGene specializes in cell lines services, protein & enzymes research, gene function studies & monoclonal antibody production solutions.See details»
Gene & cell therapy manufacturing specialist Ascend launches
May 9, 2023 Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for …See details»
Gene & cell therapy manufacturing specialist ... - World Pharma …
Ascend Gene & Cell Therapies, a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, …See details»
Gene & cell therapy manufacturing specialist Ascend
Jun 1, 2023 LONDON, May 9, 2023 — Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost …See details»
Gene & Cell Therapy Manufacturing Specialist Ascend Launches …
<p>Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy …See details»
Cathay Health Backed Ascend Gene & Cell Therapies Launches …
May 10, 2023 – Today, Cathay Health announces its investment in Ascend Gene & Cell Therapies (Ascend), a UK-based specialist CDMO (Contract Development & Manufacturing …See details»
Behind the Term Sheet: How Ascend Gene & Cell Therapies will
May 15, 2023 This is what led Cathay Health to our latest investment in Ascend Gene & Cell Therapies — a UK-headquarter, trans-Atlantic specialist CDMO (Contract Development & …See details»
Ascend Gene & Cell Therapies launches with $130M - Labiotech.eu
May 9, 2023 Ascend Gene & Cell Therapies (Ascend), a company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy …See details»
Ascend launches with over $130M of funding as expert teams merge
Mar 20, 2023 Ascend launches with over $130M of funding as expert teams merge Posted: 20 March 2023 Ascend Gene & Cell Therapies (Ascend), a specialist company innovating …See details»
Biotech Ascend Gene & Cell Therapies raises £105m - UKTN
May 9, 2023 London-based biotech firm Ascend Gene & Cell Therapies has raised $132.5m (£105.1m) for its gene therapy manufacturing technology. Founded by the VC firm Monograph …See details»
Gene & Cell Therapy Manufacturing Specialist Ascend Launches …
May 10, 2023 Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for …See details»
DCVC | Ascend partners with industry to drive down gene therapy …
Feb 7, 2024 Up to 17 cell and gene therapies are expected to be approved by regulators in 2024.Ascend CEO Mike Stella discusses how his team is working to improve manufacturing …See details»
Gene & Cell Therapy Specialist Ascend Launches with Over $130M
May 9, 2023 Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for …See details»
Cathay Health
May 10, 2023, London – Today, Cathay Health announces its investment in Ascend Gene & Cell Therapies (Ascend), a UK-based specialist CDMO (Contract Development & Manufacturing …See details»
Covington Advises on $130 Million Investment in Ascend Gene
May 15, 2023 Covington Advises on $130 Million Investment in Ascend Gene & Cell Therapies May 15, 2023. LONDON—Covington advised lead investors Abingworth and other syndicate …See details»
Behind the Term Sheet: How Ascend Gene & Cell Therapies will …
May 15, 2023 By: Jefferson Chen & Jia-Yi Har, Cathay Health The ‘holy grail’ of modern precision medicine are curative approaches, such as those exhibited in gene therapy — a …See details»